Clinical Benefits of Ruxolitinib Therapy in Myelofibrosis Patients with Varying Degrees of Splenomegaly and Symptoms Mesa, R. A., Gotlib, J., Kantarjian, H. M., Sun, W., Verstovsek, S. AMER SOC HEMATOLOGY. 2012

View details for Web of Science ID 000314049602150